Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis
- PMID: 20141608
- PMCID: PMC2855756
- DOI: 10.1111/j.1582-4934.2009.00649.x
Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis
Abstract
Beneficial effects of n-3 fatty acids (FA) on bone mineral density (BMD) have been reported in mice, rats and human beings, but the precise mechanisms involved have not been described. This study used the Fat-1 mouse, a transgenic model that synthesizes n-3 FA from n-6 FA to directly determine if outcome of bone health were correlated with n-3 FA. Ovariectomized (Ovx) and sham operated wild-type (WT) and Fat-1 mice were fed an AIN-93M diet containing 10% corn oil for 24 weeks. BMD was analysed by dual energy x-ray absorptiometry. Fat-1 Ovx mice exhibited significantly lower level of osteotropic factors like receptor activator of NF-kappaB ligand and tartrate-resistant acid phosphatase (TRAP)5b in serum and higher BMD in distal femoral metaphysis, proximal tibial metaphysis, femoral diaphysis and lumbar vertebra as compared to WT Ovx mice. LPS-stimulated bone marrow (BM) cells from Fat-1 Ovx mice produced significantly lower level of pro-inflammatory cytokines like tumour necrosis factor-alpha, interleukin (IL)-1-beta, IL-6 and higher level of anti-inflammatory cytokines like IL-10, IFN-gamma and higher level of nitric oxide as compared to BM cells from WT Ovx mice. LPS-stimulated COX-II activity as well as NF-kappaB activation in BM cells from Fat-1 Ovx mice was significantly less as compared to BM cells from WT Ovx mice. Furthermore, Fat-1 BM cells generated significantly less number of TRAP osteoclast-like cells as compared to WT BM cells. In conclusion, we offer further insight into the mechanisms involved in preventing the BMD loss in Ovx mice by n-3 FA using a Fat-1 transgenic mouse model.
Keywords: bone mineral density; inflammation; n-3 fatty acids; osteoclasts; osteoporosis.
Figures






References
-
- Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med . 2005; 353: 595–603. - PubMed
-
- Lacey JV Jr, Mink PJ, Lubin JH, et al . Menopausal hormone replacement therapy and risk of ovarian cancer. Jama . 2002; 288: 334–41. - PubMed
-
- Das UN. Essential fatty acids and osteoporosis. Nutrition . 2000; 16: 386–90. - PubMed
-
- Kruger MC, Coetzer H, de Winter R, et al . Calcium, gamma‐linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging . 1998; 10: 385–94. - PubMed
-
- Watkins BA, Lippman HE, Le Bouteiller L, et al . Bioactive fatty acids: role in bone biology and bone cell function. Prog Lipid Res . 2001; 40: 125–48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical